Summary
Background Negative attitudes towards vaccines and an uncertainty or unwillingness to receive vaccinations are major barriers to managing the COVID-19 pandemic in the long-term. We estimate predictors of four domains of negative attitudes towards vaccines and identify groups most at risk of uncertainty and unwillingness to receive a COVID-19 vaccine in a large sample of UK adults.
Methods Data were from 32,361 adults in the UCL COVID-19 Social Study. Ordinary least squares regression analyses examined the impact of socio-demographic and COVID-19 related factors on four types of negative vaccine attitudes: mistrust of vaccine benefit, worries about unforeseen effects, concerns about commercial profiteering, and preference for natural immunity. Multinomial logistic regression examined the impact of socio-demographic and COVID-19 related factors, negative vaccine attitudes, and prior vaccine behaviour on uncertainty and unwillingness to be vaccinated for COVID-19.
Findings 16% of respondents displayed high levels of mistrust or misinformation about vaccines across one or more domains. Distrustful attitudes towards vaccination were higher amongst individuals from ethnic minority backgrounds, with lower levels of education, lower annual income, poor knowledge of COVID-19, and poor compliance with government COVID-19 guidelines. Overall, 14% of respondents reported unwillingness to receive a vaccine for COVID-19, whilst 22% were unsure. The largest predictors of both COVID-19 vaccine uncertainty and refusal were low income (< £30,000 a year), having not received a flu vaccine last year, poor adherence to COVID-19 government guidelines, female gender, and living with children. Amongst vaccine attitudes, intermediate to high levels of vaccine benefit mistrust and concerns about future unforeseen side effects were the most important determinants of both uncertainty and unwillingness to vaccinate against COVID-19.
Interpretation Negative attitudes towards vaccines are major public health concerns in the UK. General mistrust in vaccines and concerns about future side effects in particular will be barriers to achieving population immunity to COVID-19 through vaccination. Public health messaging should be tailored to address these concerns.
Funding The Nuffield Foundation [WEL/FR-000022583], the MARCH Mental Health Network funded by the Cross-Disciplinary Mental Health Network Plus initiative supported by UK Research and Innovation [ES/S002588/1], and the Wellcome Trust [221400/Z/20/Z and 205407/Z/16/Z].
Evidence before this study
Evidence before this study We searched PubMed for articles published in English from 1 January 2020 to 20 September 2020 with the following keywords: (“COVID19 vaccine” OR “coronavirus vaccine”) and (“intent*” OR “refusal”). Our search found 639 titles. Several previous studies have examined predictors of intent to vaccinate for COVID-19 when it becomes available. Reasons for unwillingness to receive the COVID-19 vaccination when it becomes available centred on concerns about its newness, safety, and potential side effects. However, estimates and predictors of negative vaccine attitudes in general and how these attitudes predict uncertainty and unwillingness to vaccinate in the context of COVID-19 are unavailable.
Added value of this study
Added value of this study The attitudinal and behavioural barriers to being unsure about receiving a COVID-19 vaccine and not intending to receive one were largely overlapping; 1) didn’t get a flu vaccine last year, 2) poor adherence to government guidelines, 3) concerns about the unforeseen future effects of vaccines, and 4) and general mistrust in the benefits of vaccines.
Implications of all of the available evidence
Implications of all of the available evidence Mistrust towards vaccines represent a significant challenge in achieving the vaccination coverage required for population immunity. Taken together, there is evidence that groups most vulnerable to falling ill and dying of COVID-19 (e.g. those from ethnic minority backgrounds and who have lower incomes) have more negative attitudes towards vaccines and are less willing to vaccinate against COVID-19. Not everyone who intends to receive a COVID-19 vaccination will be able to do so because of practical barriers such as lack of accessibility and government decisions on the availability of the vaccine, underscoring the importance of improving vaccine attitudes in the general population to improve vaccine uptake amongst those who are offered a vaccine and prevent widening socio-economic health inequalities. Vaccine safety communication to increase public trust by the time a COVID-19 vaccine is available should begin now.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
Funding The Nuffield Foundation [WEL/FR-000022583], the MARCH Mental Health Network funded by the Cross-Disciplinary Mental Health Network Plus initiative supported by UK Research and Innovation [ES/S002588/1], and the Wellcome Trust [221400/Z/20/Z and 205407/Z/16/Z]. Role of the funding source The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication. All researchers listed as authors are independent from the funders and all final decisions about the research were taken by the investigators and were unrestricted. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the UCL Research Ethics Committee [12467/005] and all participants gave informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The COVID-19 Social Study documentation and codebook are available for download at https://www.covidsocialstudy.org/. Statistical code is available on request from Elise Paul (e.paul@ucl.ac.uk).
